Cargando...
ux Para una correcta visualización resolución mínima dispositivos Ipad o Tablet.

Bibliografía Consenso Español sobre el hemangioma infantil.

Bibliografía.
C. Kilcline,I.J. Frieden
Infantile hemangiomas: How common are they? A systematic review of the medical literature
Pediatr Dermatol, 25 (2008), pp. 168-173 http://dx.doi.org/10.1111/j.1525-1470.2008.00626.x
A.N. Haggstrom,B.A. Drolet,E. Baselga,S.L. Chamlin,M.C. Garzon,K.A. Horii
Prospective study of infantile hemangiomas: Clinical characteristics predicting complications and treatment
Pediatrics., 118 (2006), pp. 882-887 http://dx.doi.org/10.1542/peds.2006-0413
K.G. Chiller,D. Passaro,I.J. Frieden
Hemangiomas of infancy: Clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex
Arch Dermatol, 138 (2002), pp. 1567-1576
P. Dickison,E. Christou,O. Wargon
A prospective study of infantile hemangiomas with a focus on incidence and risk factors
Pediatr Dermatol., 28 (2011), pp. 663-669 http://dx.doi.org/10.1111/j.1525-1470.2011.01568.x
X.D. Chen,G. Ma,H. Chen,X.X. Ye,Y.B. Jin,X.X. Lin
Maternal and perinatal risk factors for infantile hemangioma: A case-control study
Pediatr Dermatol., 30 (2013), pp. 457-461 http://dx.doi.org/10.1111/pde.12042
B.A. Drolet,S.L. Chamlin,M.C. Garzon,D. Adams,E. Baselga,A.N. Haggstrom
Prospective study of spinal anomalies in children with infantile hemangiomas of the lumbosacral skin
J Pediatr., 157 (2010), pp. 789-794 http://dx.doi.org/10.1016/j.jpeds.2010.07.054
F. Corella,X. Garcia-Navarro,A. Ribe,A. Alomar,E. Baselga
Abortive or minimal-growth hemangiomas: Immunohistochemical evidence that they represent true infantile hemangiomas
J Am Acad Dermatol., 58 (2008), pp. 685-690 http://dx.doi.org/10.1016/j.jaad.2007.08.007
J. Leonardi-Bee,K. Batta,C. O’Brien,F.J. Bath-Hextall
Interventions for infantile haemangiomas (strawberry birthmarks) of the skin
Cochrane Database Syst Rev., (2011), pp. CD006545
L.C. Chang,A.N. Haggstrom,B.A. Drolet,E. Baselga,S.L. Chamlin,M.C. Garzon
Growth characteristics of infantile hemangiomas: Implications for management
Pediatrics., 122 (2008), pp. 360-367 http://dx.doi.org/10.1542/peds.2007-2767
D. Metry,G. Heyer,C. Hess,M. Garzon,A. Haggstrom,P. Frommelt
Consensus Statement on Diagnostic Criteria for PHACE syndrome
Pediatrics., 124 (2009), pp. 1447-1456 http://dx.doi.org/10.1542/peds.2009-0082
D.W. Metry,A.N. Haggstrom,B.A. Drolet,E. Baselga,S. Chamlin,M. Garzon
A prospective study of PHACE syndrome in infantile hemangiomas: Demographic features, clinical findings, and complications
Am J Med Genet A., 140 (2006), pp. 975-986 http://dx.doi.org/10.1002/ajmg.a.31189
C. Girard,M. Bigorre,B. Guillot,D. Bessis
PELVIS Syndrome
Arch Dermatol, 142 (2006), pp. 884-888 http://dx.doi.org/10.1001/archderm.142.7.884
I. Iacobas,P.E. Burrows,I.J. Frieden,M.G. Liang,J.B. Mulliken,A.J. Mancini
LUMBAR: Association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies
J Pediatr., 157 (2010), pp. 795-801 http://dx.doi.org/10.1016/j.jpeds.2010.05.027
e1-7
I.J. Frieden,M. Rogers,M.C. Garzon
Conditions masquerading as infantile haemangioma: Part 2
Australas J Dermatol., 50 (2009), pp. 153-168 http://dx.doi.org/10.1111/j.1440-0960.2009.00529_1.x
[quiz 69-70]
I.J. Frieden,M. Rogers,M.C. Garzon
Conditions masquerading as infantile haemangioma: Part 1
Australas J Dermatol., 50 (2009), pp. 77-97 http://dx.doi.org/10.1111/j.1440-0960.2009.00514_1.x
[quiz 8]
Z.R. Glick,I.J. Frieden,M.C. Garzon,T.W. Mully,B.A. Drolet
Diffuse neonatal hemangiomatosis: An evidence-based review of case reports in the literature
J Am Acad Dermatol., 67 (2012), pp. 898-903 http://dx.doi.org/10.1016/j.jaad.2012.01.018
D.W. Metry,A. Hawrot,C. Altman,I.J. Frieden
Association of solitary, segmental hemangiomas of the skin with visceral hemangiomatosis
Arch Dermatol, 140 (2004), pp. 591-596 http://dx.doi.org/10.1001/archderm.140.5.591
K.A. Horii,B.A. Drolet,I.J. Frieden,E. Baselga,S.L. Chamlin,A.N. Haggstrom
Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas
Pediatr Dermatol, 28 (2011), pp. 245-253 http://dx.doi.org/10.1111/j.1525-1470.2011.01420.x
K.B. Puttgen
Diagnosis and management of infantile hemangiomas
Pediatr Clin North Am., 61 (2014), pp. 383-402 http://dx.doi.org/10.1016/j.pcl.2013.11.010
S.L. Chamlin,A.N. Haggstrom,B.A. Drolet,E. Baselga,I.J. Frieden,M.C. Garzon
Multicenter prospective study of ulcerated hemangiomas
J Pediatr., 151 (2007), pp. 684-689 http://dx.doi.org/10.1016/j.jpeds.2007.04.055
9.e1
Baselga E, Roe E, Hernandez A, Fuentes P, Muñoz FZ, Gich I, et al. Predictors of residual lesions in infantile hemangiomas: A retrospective study, oral presentation. 20th Workshop in Vascular Anormalities. Melbourne, 2014.
E. Cohen-Barak,D. Rozenman,A. Shani Adir
Infantile haemangiomas and quality of life
Arch Dis Child., 98 (2013), pp. 676-679 http://dx.doi.org/10.1136/archdischild-2013-303745
J.M. Weinstein,S.L. Chamlin
Quality of life in vascular anomalies
Lymphat Res Biol., 3 (2005), pp. 256-259 http://dx.doi.org/10.1089/lrb.2005.3.256
S.L. Chamlin,A.J. Mancini,J.S. Lai,J.L. Beaumont,D. Cella,D. Adams
Development and validation of a quality-of-life instrument for infantile hemangiomas
J Invest Dermatol., 135 (2015), pp. 1533-1539 http://dx.doi.org/10.1038/jid.2015.18
C. Leaute-Labreze,P. Hoeger,J. Mazereeuw-Hautier,L. Guibaud,E. Baselga,G. Posiunas
A randomized, controlled trial of oral propranolol in infantile hemangioma
N Engl J Med., 372 (2015), pp. 735-746 http://dx.doi.org/10.1056/NEJMoa1404710
D.J. Hermans,J. Zweegers,A.W. Evers,C.J. van der Vleuten
Parental experiences with propranolol versus oral corticosteroids for complicated infantile hemangioma, a retrospective questionnaire study
Eur J Dermatol., 23 (2013), pp. 857-863 http://dx.doi.org/10.1684/ejd.2013.2176
I. Ostman-Smith,G. Wettrell,T. Riesenfeld
A cohort study of childhood hypertrophic cardiomyopathy: Improved survival following high-dose beta-adrenoceptor antagonist treatment
J Am Coll Cardiol., 34 (1999), pp. 1813-1822
Benowitz NL. Beta-adrenergics and blockers. En: Olson kr, FACEP, FACMT, FAACT, editores. Poisoning & drug overdose. 4th ed. New York: McGraw-Hill; 2004. p. 131-133.
C. Blanchet,R. Nicollas,M. Bigorre,P. Amedro,M. Mondain
Management of infantile subglottic hemangioma: Acebutolol or propranolol?
Int J Pediatr Otorhinolaryngol., 74 (2010), pp. 959-961 http://dx.doi.org/10.1016/j.ijporl.2010.05.013
A. Abarzua-Araya,C.P. Navarrete-Dechent,F. Heusser,J. Retamal,M.S. Zegpi-Trueba
Atenolol versus propranolol for the treatment of infantile hemangiomas: A randomized controlled study
J Am Acad Dermatol., 70 (2014), pp. 1045-1049 http://dx.doi.org/10.1016/j.jaad.2014.01.905
E. Pope,A. Chakkittakandiyil,I. Lara-Corrales,E. Maki,M. Weinstein
Expanding the therapeutic repertoire of infantile haemangiomas: Cohort-blinded study of oral nadolol compared with propranolol
Br J Dermatol., 168 (2013), pp. 222-224 http://dx.doi.org/10.1111/j.1365-2133.2012.11131.x
K.E. Holland,I.J. Frieden,P.C. Frommelt,A.J. Mancini,D. Wyatt,B.A. Drolet
Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma
Arch Dermatol., 146 (2010), pp. 775-778 http://dx.doi.org/10.1001/archdermatol.2010.158
A.L. Marqueling,V. Oza,I.J. Frieden,K.B. Puttgen
Propranolol and infantile hemangiomas four years later: A systematic review
Pediatr Dermatol., 30 (2013), pp. 182-191 http://dx.doi.org/10.1111/pde.12089
C.F. Barlow,C.J. Priebe,J.B. Mulliken,P.D. Barnes,D. Mac Donald,J. Folkman
Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy
J Pediatr., 132 (1998), pp. 527-530
M. Calvo,C. Garcia-Millan,C. Villegas,A. Fueyo-Casado,I. Buron
Topical timolol for infantile hemangioma of the eyelid
Int J Dermatol., 52 (2013), pp. 603-604 http://dx.doi.org/10.1111/j.1365-4632.2011.05290.x
M. Moehrle,C. Leaute-Labreze,V. Schmidt,M. Rocken,C.F. Poets,R. Goelz
Topical timolol for small hemangiomas of infancy
Pediatr Dermatol., 30 (2013), pp. 245-249 http://dx.doi.org/10.1111/j.1525-1470.2012.01723.x
Y. Qiu,G. Ma,J. Yang,X. Hu,H. Chen,Y. Jin
Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: A retrospective study
Clin Exp Dermatol., 38 (2013), pp. 845-850 http://dx.doi.org/10.1111/ced.12150
E.F. Mathes,A.N. Haggstrom,C. Dowd,W.Y. Hoffman,I.J. Frieden
Clinical characteristics and management of vascular anomalies: Findings of a multidisciplinary vascular anomalies clinic
Arch Dermatol., 140 (2004), pp. 979-983 http://dx.doi.org/10.1001/archderm.140.8.979
M. Luu,I.J. Frieden
Haemangioma: Clinical course, complications and management
Br J Dermatol., 169 (2013), pp. 20-30 http://dx.doi.org/10.1111/bjd.12436